chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case, initially received on 14-Oct-2016, was reported by a health professional and concerns a 44-year-old male patient. Weight: not provided; Height: not provided. Concomitant medication: not provided. Administration of company suspect drug(s): The patient received AFLURIA (thimerosal containing) from 13-OCT-2016 to 13-OCT-2016. Dose regimen: 0.5 mL, Route of administration: Intramuscular, Batch number: 12849211A. No additional suspect drugs. Adverse event description: On 13-Oct-2016, AFLURIA was administered to one patient that had some particulate material floating in the vial (outcome: not reported, special circumstances: poor quality drug administered without adverse event).
Client report having adverse reaction on 02/01/2021 at 12:28 about one hour after receiving COVID vaccine of unable to remember running a red light.  She report loss of visual memory and no recall of passing through the intersection or seeing the buildings on the corners.  Denies having blurry vision, blacking out, slurred speech or headache.  Client had a virtual doctor visit and drove to have labs drawn today without issues.
Information was received from a pharmacist referring to an unspecified patient. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 21-DEC-2016, patient  was vaccinated with the first dose of RECOMBIVAX HB for prophylaxis and received second dose in May 2017 (dose, route of administration, lot number and expiration date were not reported). No adeverse effects reported. Additional information is not expected because there was no consent to contact pharmacist.
A few weeks after my second covid vaccination I began to experience tinnitus, a constant ringing/buzzing sound in my ear, sometimes so loud it would keep from sleeping or wake me up once I had fallen asleep. Over the course of the past 2 years, after educating myself about tinnitus and seeing an ENT, I have been  able to use white noise or staying busy as distraction making the tinnitus less noticeable at times but overall it is constant all day every day buzzing/ringing in my ears. I also started having headaches out of the norm from my usual headaches and dizzy spells/vertigo around the same time of the onset of tinnitus. This was something I never experienced before therefore it caused a lot of worry and confusion  and was so difficult to manage initially that it heightened my existing depression and anxiety exponentially.
I developed a numbness radiating from my left ear and cheek that goes as far as the top of my forehead to the lower part of my neck.  I also have numbness of the lips and gums but only on the left side.  It is always present but sometimes comes on stronger.  It is a bit alarming, wondering if I am having some form of a stroke.  There is no drooping of facial muscles and am able to raise both arms etc.  I almost felt this morning that I should go to emergency at the hospital, but was afraid they wouldn't be able to detect anything and didn't want to waste their time .
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 03-JUN-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number R007150 with expiration date in 15-OCT-2019) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001849: US-009507513-1907USA001848: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001808: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000953: US-009507513-1907USA000954: US-009507513-1907USA000959: US-009507513-1907USA000962: US-009507513-1907USA000963: US-009507513-1907USA000964: US-009507513-1907USA000965: US-009507513-1907USA000966: US-009507513-1907USA000967: US-009507513-1907USA000968: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000988: US-009507513-1907USA000989:
Experienced arm pain at injection site to start, which progressed to body aches, fatigue, chills, and flu-like symptoms in the 24-48 hrs following vaccination.  Flu-like symptoms were moderate to severe.
"Covid arm" - Hot, 2" red, itchy, hard rash at injection site.  Have had this for 8 days and it's still present
Severe chills/muscle spasms Fever Muscle aches/pain Lethargy All symptoms occurred from 6 hrs post-vaccination to approximately 24 hrs
seven patients devel large welt (approx 1 1/2 inches), redness, swelling, pain @ inj site;all pt had negative allergy hx to eggs;
Pain all over, burning sensation all over. Unable to move without great effort. Could not lay on her back because of pain. The worse is the burning in "the nerves". Headache, very tired, nausea, pain on stomach, vomiting. Severe pain on legs, arms, back. When she got to MD gave her prednisone and hydrocodone. Client came on 1-23-15. C/O pain and burning sensation. No relief with medication. Called for help. They were not able to help.
I got the shot, I still got shingles; I got the shot, I still got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included SHINGRIX (received dose coupe of years before receiving double shot shingles vaccine).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 27-Jul-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The patient got the original shot.  The patient also got the new shot that was a set of 2 and they had a shingle outbreak every month for the last 2 plus years.  The shots did not help everyone. The patient got the one shot for shingles.  Then patient got the double shot a couple of years later, but he/ she still got shingles, so it did not protect you against it.  It might make it less of a severe outbreak, but you could still get it regardless of the shots. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Ringing in ears. Started the day after the first dose but subsided after a few days. Started again the day after the second dose and has continued.
Patient complaint of dizziness 15 mins after vaccine. He was given fluids. Vitals: B/P 133/93, HR 108, temp 97.3, resp 20 and SpO2 100%. Patient rested in chair for another 15 mins, feeling dizzy. After further questioning, he complained of itching and throat tightness. Patient seemed anxious, but otherwise breathing unlabored. No sign of rash and SpO2 100% on vital recheck. Ambulance called at 1651 and arrived at 1700. Patient taken to nearest hospital for evaluation and monitoring.
Symptoms started around 9 pm that night. Terrible body aches, fever, headache, chills, nausea
Dizziness; major pain at injection site and surrounding area of arm; major pain at injection site and surrounding area of arm; headache; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 51 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 16Feb2021 09:30 (Batch/Lot Number: EN5318) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included bupropion (BUPROPION) taken for an unspecified indication, start and stop date were not reported; fluoxetine (FLUOXETINE) taken for an unspecified indication, start and stop date were not reported; trazodone (TRAZODONE) taken for an unspecified indication, start and stop date were not reported; propranolol (PROPANOLOL [PROPRANOLOL]) taken for an unspecified indication, start and stop date were not reported; levofloxacin (LEVO [LEVOFLOXACIN]) taken for an unspecified indication, start and stop date were not reported. The patient previously took levaquin and experienced drug hypersensitivity, amoxicillin and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation. The patient experienced dizziness on 16Feb2021 11:00 with outcome of recovering, major pain at injection site and surrounding area of arm leading to vaccination site pain on 16Feb2021 11:00 with outcome of recovering, major pain at injection site and surrounding area of arm leading to pain in extremity on 16Feb2021 11:00 with outcome of recovering and headache on 16Feb2021 11:00 with outcome of recovering.  No follow-up attempts are possible. No further information is expected.
12/03/2004 developed rash on left arm, several lesions, some pustular, spread to arm, trunk and legs. Impression is erythema multiforme versus generalized vaccinia. Recommended symptomatic treatment: anti-histamine such as Benadryl and analgesic acetominopphen. Recommended contact precautions until lesions have resolved.
Patient reports that on Monday they experienced bright red blood per rectum and after, felt light-headed and fell to the floor. She is uncertain whether or not there was loss of consciousness. The patient reports that she felt better on Tuesday, but had an additional episode of bright red blood per rectum today and decided to be evaluated. She does have guiac(+) stool and was found to have a non-bleeding external hemorrhoid. The patient is being admitted to the hospital.
while waiting after receiving immunization, patient lost consciousness and fell onto floor , he was lying on stomach and seized a few times before regaining consciousness.  we placed him on his side and had him continue to lie on floor until he felt like sitting up.  we placed a cold compress on forehead and gave patient water to drink after he had recovered and was sitting up.  he remained sitting on floor for approximately 30 minutes and then said he felt ok to leave
p/vax pt exp fever & devel chickenpox w/13 red raised lesions on legs, back & chin & one pustule on face;pt sought unspecified medical attention;
swelling; warmth; cold symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold symptoms), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE WARMTH (warmth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001b21a) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced NASOPHARYNGITIS (cold symptoms). On 18-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling) and VACCINATION SITE WARMTH (warmth). At the time of the report, NASOPHARYNGITIS (cold symptoms), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE WARMTH (warmth) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  Treatment information was not provided. Lab details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received contains no new information.
Day 1 - Soreness at injection site (left deltoid) Day 2 - Soreness at injection site (left deltoid), fatigue, bilateral lymph nodes below ear and behind jaw sore Day 3 - Soreness subsiding, fatigue Day 4 - Soreness to injection site absent; lymph node(?) soreness and pain lateral chest/breast area anterior to axilla Day 5 - Soreness to lymph node remains Day 6 - Soreness to lymph node subsiding Day 7 - Soreness to left deltoid returned. Day 8 - Large flat area of erythema around and below injection site appeared, hot to touch.
01/06/2022 - Severe back paint 03/22/2022 - Diagnosed with spinal tumors (2)
Eczema appeared on my knees, elbows, right foot, and the palm of my right hand. Treated at home with moisturizers and all sites went away except my hand. Waited until the itching was unbearable, and then went to the dermatologist July 19. She prescribed triamcinolone acetonide .1%. The eczema is still on my hand, but some of it has cleared.
1 of 2 pts devel inject site reacts the size of a football; no cultures taken; pt was treated w/ATB x 7 days; poss cellulitis; pt recovered;
there was no adverse event.  Patient received 3rd dose Pfizer in error.  First two doses were Moderna.  Does not qualify for a 3rd Moderna dose (not immunocompromised).
Facial neuralgia started March 20th. Left side, severe. Bell's Palsy developed March 23rd, left side. Ramsay Hunt Syndrome - Prescribed 7 day course of prednisone, valacyclovir. Started Gabapentin 300mg 3x/day.
Inadvertently administered three doses of varicella (2/14/03) (12/01/06). No known s/sx.
The next two nights, I could not sleep on left arm. The left deltoid was tender to touch. The left side of my neck was also achey for two or three days after vaccination. (That's all on the evening of Jan 24 & 25.)  The following day (Jan 24), I was very itchy. I kept thinking a bug was crawling on me...but when I went to brush it off, nothing was there...
tested positive for covid-19; tested positive for covid-19; This is a spontaneous report from a Pfizer-sponsored program. A contactable male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection,Lot number was not reported), dose 1 via an unspecified route of administration on 23Feb2021  as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient received the first dose of the covid-19 vaccine on and then tested positive for covid-19. Patient queried if he should receive the second vaccine. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Bouts of Rapid heart rate. My normal resting heart rate is usually between 58-68 bpm.  I was having bouts of rapid heart rate up to 99 bpm. The bouts would last a couple of minutes up to 10 minutes and left me feeling exhausted like I wasn?t getting enough air no matter how many deep breaths I took.
unilateral Right sided muscular spasms in both upper and lower extremities; onset 1 day after injection
Within 12-14 hours of getting the Maderna shot(1st shot), not only did I have a sore arm, but my shoulder had pain. Each day the pain got a little worse and started stretching to my chest. My chest and heart were uncomfortable. My wife was having the same symptoms so we just tried to manage through the pain. One April 28, the pain was so severe it woke me up in the middle of the night. I took some antacids and that seemed to help. The next 3 days the pain was on and off until May 1 evening, the pain was so severe and I was vomiting that we decided to go to the hospital. It was determined that I had a heart attack.
Error occurred when administering a dose of Pediatric Pfizer Bivalent vaccine. Clinic staff did not dilute vaccine vial prior to administration and so patient received concentrated vaccine. Estimated dose administered ~28 mcg rather than intended 10 mcg.  Patient/caregiver did not report any adverse event.
Patient called and spoke to the store manager on 10/26 and said she was just discharged from the hospital. She said her face blew up because of the flu shot. Hospital ran various tests and nothing seem wrong. She refused to speak to a pharmacist.
I exp headache, chills, fever, achiness and  around 4:00 pm I felt better. I was able to sit up no symptoms.
Site redness and swelling 8:00 PM 10/23/2012 --  Slight nausea and vertigo on 10/24/2012. -- Severe vertigo, headache and nausea on 10/25/2012 --- continues on 10/26/2012 even with medication.
Slight confusion; Slight dizziness; Itching; Redness of skin; Some numbness of throat; Tingling lips; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm right on 05Apr2021 at 14:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown whether the patient had any known allergies to medications, food or other products. Concomitant medications included vitamin D nos (VITAMIN D) 50,000 IU, levothyroxine (MANUFACTURER UNKNOWN) 100 mg and vitamin E nos (VITAMIN E) all for an unknown indications, from an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 14:30 the patient experienced slight confusion which abated within first 5 minutes after injection, slight dizziness, itching, redness of skin, some numbness of throat and  tingling lips. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of reported events. The clinical outcome of the event slight confusion which abated within first 5 minutes after injection i.e. 05Apr2021 at 14:35, slight dizziness, itching, redness of skin, some numbness of throat and tingling lips was recovered on 05Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Dizziness; room spinning; Loss of balance; Nausea; This is a spontaneous report received from a contactable consumer (patient). A 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE,solution for injection; lot number- EW0176 and expiry date not reported) via an unspecified route of administration into Left arm on 06Aug2021 15:00, at the age of 65-year-old,dose1, single for COVID-19 immunization in a Pharmacy or Drug Store. Relevant medical history includes allergies to Indocin and Tramadol. Concomitant medications include allopurinol and Synthroid. The patient did not receive other vaccine in four weeks. The patient did not have prior COVID vaccination and was not tested post vaccination. On 15Aug2021 9:00,the patient experienced dizziness, room spinning,loss of balance and nausea. The patient did not receive treatment in response to the events. The outcome of the events was not recovered at the time of report.
Is it possible the shingles vaccine could trigger an autoimmune problem in the form of rheumatoid arthritis?  My shot was on Oct 1, 2012 and within a week I was in great pain. Following blood work, I have been diagnosed with rheumatoid arthritis. Please check out and get back to me.
pt recv vax & devel arthritis & delayed hypersensitivity; No further details were provided;
First vaccine, 4/3/2021, Janssen, Lot 041A21A. First Booster, 11/08/2021, Moderna, Lot 014F21A. Second Booster, 04/07/2022, Moderna Lot 041J21A.
Mild tingling on the right side of her mouth and face that started shortly after receiving the vaccination. Symptoms were less intense and lasted for a shorter period of time than after the first injection.
Initial information received from other company (Merck service request number 1-7281445344) on 31 May 2013. The information was initially reported by a consumer. A female patient, whose age, medical history and concomitant medications were not reported, had received a dose of TDAP vaccine (lot number, dose number, route and anatomical site of administration were not reported) on an unspecified date. On an unspecified date, after vaccination, the patient developed an allergic reaction to the Pertussis Laboratory investigations and corrective treatments were not reported. At the time of this report, the outcome of the event was not reported. List of documents held by sender: none.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unspecified age. Information about the patient's concurrent condition, concomitant medication or medical history was not provided. On or around 25-JUL-2014, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (strength, dose, route, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  On an unspecified date (reported as shortly after the vaccination), the patient suffered a bad case of the shingles. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), her symptoms have resulted in physical limitations not present prior to using the product. Patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the vaccine, she suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of shingles was considered as not recovered. The reporter considered the event to be disable and related to Zoster Vaccine Live(ZOSTAVAX).